Oral Human Papillomavirus Infection in HIV-infected Men
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00421486 |
Recruitment Status
: Unknown
Verified January 2016 by Alexander Kreuter, Deutsche Luft und Raumfahrt.
Recruitment status was: Recruiting
First Posted
: January 12, 2007
Last Update Posted
: January 21, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Papillomavirus Infections HIV Infections | Procedure: Oral swabs for HPV-typing and high-risk HPV-determination |
Study Type : | Observational |
Estimated Enrollment : | 500 participants |
Observational Model: | Case Control |
Time Perspective: | Prospective |
Official Title: | Incidence, Prevalence, Spectrum of HPV-types, and Viral Load Determination of High-risk Human Papillomavirus Infection of the Oral Cavity in HIV-infected Men Who Have Sex With Men |
Study Start Date : | March 2006 |
Estimated Primary Completion Date : | January 2017 |
Estimated Study Completion Date : | January 2018 |

-
Procedure: Oral swabs for HPV-typing and high-risk HPV-determination
- Spectrum of HPV types and associated clinical lesions [ Time Frame: swabs will be obtained approximately every 6 months ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Probability Sample |
Inclusion Criteria:
- HIV-infected men who have sex with men
Exclusion Criteria:

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00421486
Contact: Alexander Kreuter, MD | 0049/234/5093439 | a.kreuter@derma.de |
Germany | |
Department of Dermatology, Ruhr University Bochum | Recruiting |
Bochum, NRW, Germany, 44791 | |
Contact: Alexander Kreuter, MD 0049/234/5093439 a.kreuter@derma.de | |
Principal Investigator: Alexander Kreuter, MD | |
Principal Investigator: Norbert Brockmeyer, MD | |
Institute of Virology, University of Cologne | Recruiting |
Köln, NRW, Germany, 50935 | |
Contact: Ulrike Wieland, MD | |
Principal Investigator: Ulrike Wieland, MD |
Principal Investigator: | Alexander Kreuter, MD | Department of Dermatology, Ruhr University Bochum | |
Principal Investigator: | Norbert Brockmeyer, MD | Department of Dermatology, Ruhr University Bochum | |
Principal Investigator: | Ulrike Wieland, MD | Institute of Virology, University of Cologne |
Additional Information:
Responsible Party: | Alexander Kreuter, Prof. Dr., Deutsche Luft und Raumfahrt |
ClinicalTrials.gov Identifier: | NCT00421486 History of Changes |
Other Study ID Numbers: |
01 KI 0501 |
First Posted: | January 12, 2007 Key Record Dates |
Last Update Posted: | January 21, 2016 |
Last Verified: | January 2016 |
Keywords provided by Alexander Kreuter, Deutsche Luft und Raumfahrt:
Oral human papillomavirus infection HIV-infection High-risk HPV viral load |
Oral human papillomavirus infection in HIV-positive men Treatment Experienced Treatment Naive |
Additional relevant MeSH terms:
Infection Communicable Diseases HIV Infections Papillomavirus Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections |
Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases DNA Virus Infections Tumor Virus Infections |